Subchronic physostigmine pretreatment in guinea pigs: Effective against soman and without side effects

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 4, 1998, Pages 1061-1067

  Philippens, Ingrid H C H M ^a   Busker, Ruud W ^a   Wolthuis, Otto L ^a   Olivier, Berend ^b   Bruijnzeel, Piet L B ^a   Melchers, Bert P C ^a  

^a TNO   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Behavior; Cholinesterase; Electrophysiology; Guinea pig; Muscarinergic receptor; Physostigmine; Pretreatment; Scopolamine; Soman; Subchronic

Indexed keywords

CHEMICAL WARFARE AGENT; CHOLINESTERASE INHIBITOR; PHYSOSTIGMINE; SCOPOLAMINE; SOMAN;

ANIMAL EXPERIMENT; ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG INTOXICATION; GUINEA PIG; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ACETYLCHOLINESTERASE; ANIMALS; AVOIDANCE LEARNING; CHOLINESTERASE INHIBITORS; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EVOKED POTENTIALS, VISUAL; GUINEA PIGS; MALE; MUSCARINIC ANTAGONISTS; PHYSOSTIGMINE; RECEPTORS, CHOLINERGIC; RECEPTORS, MUSCARINIC; SCOPOLAMINE; SOMAN; STARTLE REACTION;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0032053167     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00511-X     Document Type: Article

References (35)

1. Albuquerque E. X., Aracava Y., Cintra W. M., Brossi A., Schonenberger B., Deshpande S. S. Structure-activity relationship of reversible cholinesterase inhibitors. Activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex Braz. J. Med. Biol. Res. 21:1988;1173-1196.
2. Ali-Melkkila T., Kanto J., Isalo E. Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anaesthesiol. Scand. 37:1993;633-642.
3. Baker H. F., Barratt N. G., Crow T. J., Ridley R. M. Learning impairment produced by presynaptic acetylcholine depletion in marmosets. J. Physiol. 350:1984;70P.
4. Baskin P. P., Gianutso G., Salamone J. D. Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding. Pharmacol. Biochem. Behav. 49:1994;437-442.
5. Berry W. K., Davies D. R. The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2,-trimethylpropyl methylphosphonofluoridate. Biochem. Pharmacol. 19:1970;927-934.
6. Bhat R. V., Turner S. L., Marks M. J., Collins A. C. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion. J. Pharmacol. Exp. Ther. 255:1990;187-196.
7. Cintron N. M., Chen Y. M. A sensitive radioreceptor assay for determining scopolamine in plasma and urine. J. Pharm. Sci. 76:1987;328-332.
8. Costa L. G., Schwab B. W., Murphy S. D. Tolerance to anticholinesterase compounds in mammals. Toxicology. 25:1982;79-97.
9. Dirnhuber P., French M. C., Green D. M., Leadbeater L., Stratton J. A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 31:1979;295-299.
10. Gall D. The use of therapeutic mixtures in the treatment of cholinesterase inhibition. Fundam. Appl. Toxicol. 1:1981;214-216.
11. Gazit H., Silman I., Dudai Y. Administration of organophosphate causes a decrease in muscarinic receptor levels in rat brain. Brain Res. 174:1981;351-356.
12. Gordon J. J., Leadbeater L. The prophylactic use of 1-methyl, 2-hydroxyiminomethylpyridinium methanesulfonate (P2S) in the treatment of organophosphate poisoning. Toxicol. Appl. Pharmacol. 40:1977;109-114.
13. Gordon J. J., Leadbeater L., Maidment M. P. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 43:1978;207-216.
14. Harris L. W., Anderson D. R., Lennox W. J., Solana R. P. Effects of subacute administration of physostigmine on blood acetylcholinesterase activity, motor performance, and soman intoxication. Toxicol. Appl. Pharmacol. 97:1989;267-271.
15. Harris L. W., Stitcher D. L., Heyl W. C. The effects of pretreatments with carbamates, atropine, and mecamylamine on survival and on soman-induced alterations in the rat and rabbit brain acetylcholine. Life Sci. 26:1980;1885-1891.
16. Hong S. J., Chang C. C. Run-down of neuromuscular transmission during repetitive nerve activity by nicotic antagonists is not due to desensitization of the postsynaptic receptor. Br. J. Pharmacol. 102:1991;817-822.
17. Inns R. H., Leadbeater L. The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig. J. Pharm. Pharmacol. 35:1983;427-433.
18. Johnson C. D., Russell R. L. A rapid, simple radiometric assay for cholinesterase suitable for multiple determinations. Anal. Biochem. 64:1975;229-238.
19. Leadbeater L., Inns R. H., Rylands J. M. Treatment of poisoning by soman. Fundam. Appl. Toxicol. 5:1985;S225-S231.
20. Lim D. K., Hoskins B., Ho I. K. Evidence for the involvement of presynaptic cholinergic functions in tolerance to diisopropylfluorophosphate. Toxicol. Appl. Pharmacol. 90:1987;465-476.
21. Lim D. K., Ito Y., Yu Z. J., Hoskins B., Ho I. K. Prevention of soman toxicity after the continuous administration of physostigmine. Pharmacol. Biochem. Behav. 31:1989;633-639.
22. McLachlan E. M., Martin A. R. Nonlinear summation of end-plate potentials in the frog and mouse. J. Physiol. 311:1981;307-324.
23. Melchers, B. P. C.; Van der Laaken, A. L.: Differential effects of chronic treatment with the organophosphorus AChE-inhibitors soman and DFP on quantal transmitter release at the neuromuscular junction. Institute Report. MBL A27/M/168; 1990.
24. Philippens I. H. C. H. M., Melchers B. P. C., Wolthuis O. L. Active avoidance in guinea pigs, effects of physostigmine and scopolamine. Pharmacol. Biochem. Behav. 42:1992;285-289.
25. Philippens I. H. C. H. M., Wolthuis O. L., Busker R. W., Langenberg J. P., Melchers B. P. C. Side effects of physostigmine as a pretreatment in guinea pigs. Pharmacol. Biochem. Behav. 55:1996;99-105.
26. Philippens I. H. C. H. M., Olivier B., Melchers B. P. C. Effects of physostigmine on the startle in guinea pigs. Two mechanisms involved Pharmacol. Biochem. Behav. 58:1997;1-5.
27. Provan S. D., Miyamoto M. D. Tetrahydroaminoacridine and physostigmine have opposing effects on probability of transmitter release at the frog neuromuscular junction. Neurosci. Lett. 123:1991;127-130.
28. Ridley R. M., Barratt N. G., Baker H. F. Cholinergic learning deficits in the marmoset produced by scopolamine and ICV hemicholinium. Psychopharmacology (Berlin). 83:1984;340-345.
29. Thomsen R. H., Wilson D. F. Neuromuscular transmission changes associated with tolerance development after chronic exposure to diisopropylfluorophosphate. J. Pharmacol. Exp. Ther. 247:1988;635-639.
30. Tiedt T. N., Albuquerque E. X., Hudson C. J., Raoh J. E. Neostigmine induced alterations at the mammalian neuromuscular junction I. Muscle contractions and electrophysiology J. Pharmacol Exp. Ther. 205:1978;326-329.
31. Van Dongen C. J., Wolthuis O. L. On the development of behavioral tolerance to organophosphates I. Biochemical and behavioral aspects Pharmacol. Biochem. Behav. 34:1989;471-481.
32. Van Helden H. P. M., Zijlstra J. J., van der Wiel H. J., Melchers B. P. C., Busker R. W. Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLÖ-7, HGG-12, HGG-42 and obidoxime following nonreactivatable acetylcholinesterase-inhibition in rats. Arch. Toxicol. 68:1994;224-230.
33. Wetherell J. R. Continous administration of low dose rates of physostigmine and hyoscine to guinea pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning. J. Pharm. Pharmacol. 46:1994;1023-1028.
34. Wolthuis O. L., Philippens I. H. C. H. M., Vanwersch R. A. P. On the development of behavioral tolerance to organophosphates III. Behavioral aspects Pharmacol. Biochem. Behav. 35:1990;561-565.
35. Wolthuis O. L., Groen B., Busker R. W., van Helden H. H. P. M. Effects of low doses of cholinesterase inhibitors on behavioral performance of robot-tested marmosets. Pharmacol. Biochem. Behav. 51:1995;443-456.